{
    "@context": {
        "schema": "https://schema.org/",
        "dct": "http://purl.org/dc/terms/",
        "hg": "https://hormuz.group/data/ns#"
    },
    "id": "hg:company:soha-pharmaceutical-company",
    "identifier": "hg:company:soha-pharmaceutical-company",
    "dataset_type": "entity_dataset",
    "entity_type": "company",
    "data_version": "2.0",
    "generated_by": "Hormuz Data Layer 0.2.1",
    "generated_at": "2026-07-04T02:51:17+00:00",
    "name": "Soha Pharmaceutical Company",
    "slug": "soha-pharmaceutical-company",
    "status": "publish",
    "url": "https://hormuz.group/companies/soha-pharmaceutical-company/",
    "json_url": "https://hormuz.group/wp-content/uploads/hormuz-data/cpt/company/soha-pharmaceutical-company.json",
    "rest_url": "https://hormuz.group/wp-json/hormuz-data/v1/cpt/company/soha-pharmaceutical-company",
    "summary": "",
    "machine_summary": "Soha Pharmaceutical Company Soha Pharmaceutical Company is an unlisted Iranian pharmaceutical manufacturer connected to the Red Crescent medical-procurement ecosystem. In the Hormuz Group company graph, it matters because it links domestic medicine manufacturing, public-health supply, Red Crescent institutional procurement, common therapeutic categories, GMP compliance, and regional export ambitions. Its factories and public-health affiliation make it relevant to healthcare resilience even without ordinary equity-market listing. Soha Pharmaceutical is relevant for investors assessing Iran's institutional pharmaceutical supply, domestic generic-drug manufacturing, public-health procurement, medicine shortages, and the role of semi-public health organizations in drug production. It can support analysis of therapeutic breadth, pricing regulation, distribution links, regulatory compliance, and export positioning in nearby markets. Due diligence should verify ownership by Red Crescent-related entities, current legal status, factory locations, product registrations, GMP certificates, updated production continuity, distributor arrangements, receivables, API sourcing, and any separation between Soha Pharmaceutical, Soha Helal distribution, and Soha medical-equipment entities. Soha Pharmaceutical Company manufactures human pharmaceutical products across categories including antibiotics, antifungals, cardiovascular drugs, diabetes medicines, endocrine-system drugs, gastrointestinal drugs, kidney-failure medicines, neurological drugs, painkillers, anti-inflammatory drugs, antihistamines, respiratory medicines, skin medicines, urological drugs, lipid-lowering products, supplements, and related oral or general pharmaceutical preparations. province: Tehran industry: Healthcare & Pharma, Manufacturing, Pharmaceuticals market: Consumer Demand, Healthcare, Materials, Supply Chains challenges: Compliance, Import Dependence, Supply Shortage, Technology Gap company_type: Manufacturer city: Tehran",
    "published_at": "2026-06-28T20:29:04+00:00",
    "modified_at": "2026-06-28T20:29:04+00:00",
    "taxonomies": {
        "province": [
            {
                "id": 3,
                "name": "Tehran",
                "slug": "tehran",
                "url": "https://hormuz.group/provinces/tehran/"
            }
        ],
        "industry": [
            {
                "id": 21,
                "name": "Healthcare & Pharma",
                "slug": "healthcare-pharma",
                "url": "https://hormuz.group/industry/healthcare-pharma/"
            },
            {
                "id": 16,
                "name": "Manufacturing",
                "slug": "manufacturing",
                "url": "https://hormuz.group/industry/manufacturing/"
            },
            {
                "id": 121,
                "name": "Pharmaceuticals",
                "slug": "pharmaceuticals",
                "url": "https://hormuz.group/industry/healthcare-pharma/pharmaceuticals/"
            }
        ],
        "market": [
            {
                "id": 34,
                "name": "Consumer Demand",
                "slug": "consumer-demand",
                "url": "https://hormuz.group/market/consumer-demand/"
            },
            {
                "id": 69,
                "name": "Healthcare",
                "slug": "healthcare",
                "url": "https://hormuz.group/market/consumer-demand/healthcare/"
            },
            {
                "id": 73,
                "name": "Materials",
                "slug": "materials",
                "url": "https://hormuz.group/market/enterprise-demand/materials/"
            },
            {
                "id": 76,
                "name": "Supply Chains",
                "slug": "supply-chains",
                "url": "https://hormuz.group/market/enterprise-demand/supply-chains/"
            }
        ],
        "challenges": [
            {
                "id": 164,
                "name": "Compliance",
                "slug": "compliance",
                "url": "https://hormuz.group/challenges/regulatory-barriers/compliance/"
            },
            {
                "id": 176,
                "name": "Import Dependence",
                "slug": "import-dependence",
                "url": "https://hormuz.group/challenges/market-gaps/import-dependence/"
            },
            {
                "id": 177,
                "name": "Supply Shortage",
                "slug": "supply-shortage",
                "url": "https://hormuz.group/challenges/market-gaps/supply-shortage/"
            },
            {
                "id": 179,
                "name": "Technology Gap",
                "slug": "technology-gap",
                "url": "https://hormuz.group/challenges/market-gaps/technology-gap/"
            }
        ],
        "company_type": [
            {
                "id": 299,
                "name": "Manufacturer",
                "slug": "manufacturer",
                "url": "https://hormuz.group/company-type/manufacturer/"
            }
        ],
        "city": [
            {
                "id": 384,
                "name": "Tehran",
                "slug": "tehran",
                "url": "https://hormuz.group/cities/tehran/"
            }
        ]
    },
    "taxonomy_labels": {
        "province": "Tehran",
        "industry": "Healthcare & Pharma, Manufacturing, Pharmaceuticals",
        "market": "Consumer Demand, Healthcare, Materials, Supply Chains",
        "challenges": "Compliance, Import Dependence, Supply Shortage, Technology Gap",
        "company_type": "Manufacturer",
        "city": "Tehran"
    },
    "fields_summary": {
        "legal_name": "Soha Pharmaceutical Company",
        "website": "https://www.sohapharma.ir",
        "city": "Tehran, Tehran Province, Iran",
        "ticker_symbol": "",
        "listing_status": "unlisted",
        "products_services": "Soha Pharmaceutical Company manufactures human pharmaceutical products across categories including antibiotics, antifungals, cardiovascular drugs, diabetes medicines, endocrine-system drugs, gastrointestinal drugs, kidney-failure medicines, neurological drugs, painkillers, anti-inflammatory drugs, antihistamines, respiratory medicines, skin medicines, urological drugs, lipid-lowering products, supplements, and related oral or general pharmaceutical preparations.",
        "export_relevance": "medium",
        "short_profile": "Soha Pharmaceutical Company is an unlisted Iranian pharmaceutical manufacturer connected to the Red Crescent medical-procurement ecosystem. In the Hormuz Group company graph, it matters because it links domestic medicine manufacturing, public-health supply, Red Crescent institutional procurement, common therapeutic categories, GMP compliance, and regional export ambitions. Its factories and public-health affiliation make it relevant to healthcare resilience even without ordinary equity-market listing.",
        "investment_relevance": "Soha Pharmaceutical is relevant for investors assessing Iran's institutional pharmaceutical supply, domestic generic-drug manufacturing, public-health procurement, medicine shortages, and the role of semi-public health organizations in drug production. It can support analysis of therapeutic breadth, pricing regulation, distribution links, regulatory compliance, and export positioning in nearby markets. Due diligence should verify ownership by Red Crescent-related entities, current legal status, factory locations, product registrations, GMP certificates, updated production continuity, distributor arrangements, receivables, API sourcing, and any separation between Soha Pharmaceutical, Soha Helal distribution, and Soha medical-equipment entities."
    },
    "fields": {
        "rank_math_internal_links_processed": "1",
        "wp_statistics_words_count": "0",
        "legal_name": "Soha Pharmaceutical Company",
        "city": "Tehran, Tehran Province, Iran",
        "ticker_symbol": "",
        "export_relevance": "medium",
        "verification_status": "basic",
        "data_confidence": "high",
        "listing_status": "unlisted",
        "last_updated": "29/06/2026",
        "website": "https://www.sohapharma.ir",
        "products_services": "Soha Pharmaceutical Company manufactures human pharmaceutical products across categories including antibiotics, antifungals, cardiovascular drugs, diabetes medicines, endocrine-system drugs, gastrointestinal drugs, kidney-failure medicines, neurological drugs, painkillers, anti-inflammatory drugs, antihistamines, respiratory medicines, skin medicines, urological drugs, lipid-lowering products, supplements, and related oral or general pharmaceutical preparations.",
        "short_profile": "Soha Pharmaceutical Company is an unlisted Iranian pharmaceutical manufacturer connected to the Red Crescent medical-procurement ecosystem. In the Hormuz Group company graph, it matters because it links domestic medicine manufacturing, public-health supply, Red Crescent institutional procurement, common therapeutic categories, GMP compliance, and regional export ambitions. Its factories and public-health affiliation make it relevant to healthcare resilience even without ordinary equity-market listing.",
        "investment_relevance": "Soha Pharmaceutical is relevant for investors assessing Iran's institutional pharmaceutical supply, domestic generic-drug manufacturing, public-health procurement, medicine shortages, and the role of semi-public health organizations in drug production. It can support analysis of therapeutic breadth, pricing regulation, distribution links, regulatory compliance, and export positioning in nearby markets. Due diligence should verify ownership by Red Crescent-related entities, current legal status, factory locations, product registrations, GMP certificates, updated production continuity, distributor arrangements, receivables, API sourcing, and any separation between Soha Pharmaceutical, Soha Helal distribution, and Soha medical-equipment entities.",
        "source_note": "Based on public company, official-company, pharmaceutical-sector, Red Crescent medical-procurement, product, GMP, and market-related information. Further verification is required before treating this profile as verified investment intelligence."
    },
    "field_profile": {
        "rank_math_internal_links_processed": {
            "type": "string",
            "present": true,
            "length": 1
        },
        "wp_statistics_words_count": {
            "type": "string",
            "present": true,
            "length": 1
        },
        "legal_name": {
            "type": "string",
            "present": true,
            "length": 27
        },
        "city": {
            "type": "string",
            "present": true,
            "length": 29
        },
        "ticker_symbol": {
            "type": "string",
            "present": false,
            "length": 0
        },
        "export_relevance": {
            "type": "string",
            "present": true,
            "length": 6
        },
        "verification_status": {
            "type": "string",
            "present": true,
            "length": 5
        },
        "data_confidence": {
            "type": "string",
            "present": true,
            "length": 4
        },
        "listing_status": {
            "type": "string",
            "present": true,
            "length": 8
        },
        "last_updated": {
            "type": "string",
            "present": true,
            "length": 10
        },
        "website": {
            "type": "string",
            "present": true,
            "length": 25
        },
        "products_services": {
            "type": "string",
            "present": true,
            "length": 466
        },
        "short_profile": {
            "type": "string",
            "present": true,
            "length": 506
        },
        "investment_relevance": {
            "type": "string",
            "present": true,
            "length": 753
        },
        "source_note": {
            "type": "string",
            "present": true,
            "length": 244
        }
    },
    "sources": [
        {
            "type": "note",
            "value": "Based on public company, official-company, pharmaceutical-sector, Red Crescent medical-procurement, product, GMP, and market-related information. Further verification is required before treating this profile as verified investment intelligence."
        }
    ],
    "quality": {
        "required_fields": [
            "legal_name",
            "website",
            "city",
            "listing_status",
            "products_services",
            "export_relevance",
            "verification_status",
            "data_confidence",
            "short_profile",
            "investment_relevance",
            "source_note",
            "last_updated"
        ],
        "missing_required_fields": [],
        "missing_required_count": 0,
        "verification_status": "basic",
        "data_confidence": "high",
        "last_updated": "29/06/2026",
        "stale_over_180_days": false,
        "quality_score": 100
    },
    "verification": {
        "verification_status": "basic",
        "data_confidence": "high",
        "last_updated": "29/06/2026"
    }
}